Menu Search
Equities

Koninklijke Philips NV

PHG:NYQ

Koninklijke Philips NV

Actions
Health CareMedical Equipment and Services
  • Price (USD)26.38
  • Today's Change0.07 / 0.27%
  • Shares traded553.24k
  • 1 Year change+29.17%
  • Beta0.7589
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy1
Outperform0
Hold1
Sell0
Strong Sell1

Share price forecast in EUR

The 3 analysts offering 12 month price targets for Koninklijke Philips NV (ADR) have a median target of 27.95, with a high estimate of 36.43 and a low estimate of 18.66. The median estimate represents a 6.24% increase from the last price of 26.31.
High38.5%36.43
Med6.2%27.95
Low-29.1%18.66

Dividends in EUR

Historical dividend information is not available for Koninklijke Philips NV.
Div growth (TTM)-100.00%
More ▼

Earnings history & estimates in EUR

On Oct 28, 2024, Koninklijke Philips NV (ADR) reported 3rd quarter 2024 earnings of 0.32 per share.
The next earnings announcement is expected on Jan 27, 2025.
Average growth rate+2.43%
Koninklijke Philips NV (ADR) reported annual 2023 earnings of 1.25 per share on Jan 29, 2024.
Average growth rate-7.34%
More ▼

Revenue history & estimates in EUR

Koninklijke Philips NV (ADR) had 3rd quarter 2024 revenues of 4.38bn. This missed the 4.54bn consensus estimate of the 4 analysts following the company. This was 5.04% above the prior year's 3rd quarter results.
Average growth rate+0.22%
Koninklijke Philips NV (ADR) had revenues for the full year 2023 of 18.17bn. This was 1.92% above the prior year's results.
Average growth rate-1.64%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.